RESUMO
We investigated the clinical efficacy of direct hemoperfusion with a beta2-microglobulin (beta2-m) adsorption column for the treatment of patients with dialysis-related amyloidosis. A 2-year prospective controlled study was performed to compare the effects of passaging blood through a (beta2-m) adsorption column (Lixelle) before it is passaged through the dialysis polysulfone membrane on the severity of amyloidosis in these individuals. Patients (n = 22) whose blood went through the Lixelle column prior to dialysis had a higher beta2-m removal rate compared to an equal number of controls, and they showed earlier improvement in their symptoms which included impaired daily activities, joint stiffness, and pain. The appearance of additional bone cysts was prevented in pre-adsorbed patients but not in the controls. Thus, the Lixelle column is useful in preventing the progression of dialysis-related amyloidosis and in ameliorating or arresting the progression of the symptoms of this disorder.
Assuntos
Amiloidose/prevenção & controle , Cistos Ósseos/prevenção & controle , Hemoperfusão/métodos , Diálise Renal/efeitos adversos , Microglobulina beta-2/sangue , Atividades Cotidianas , Amiloidose/etiologia , Amiloidose/fisiopatologia , Artrografia , Cistos Ósseos/etiologia , Cistos Ósseos/fisiopatologia , Feminino , Força da Mão/fisiologia , Humanos , Articulações/fisiopatologia , Masculino , Pessoa de Meia-Idade , Dor/fisiopatologia , Manejo da Dor , Estudos ProspectivosRESUMO
BACKGROUND: The so-called "intact parathyroid hormone (iPTH)" assay detects large C-terminal PTH fragments that are lacking several N-terminal amino acid residues in addition to 1-84 PTH molecules. METHODS: Blood samples were obtained from 65 predialysis patients (male, 35; female, 30) and 109 dialysis patients (male, 73; female, 36). The plasma 1-84 PTH levels were determined by a specific immunoradiometric assay (IRMA). RESULTS: The ratio of 1-84 PTH/iPTH did not show a significant correlation with glomerular filtration rate (GFR) among patients with a GFR of more than 80 ml/min, while it showed a positive correlation with GFR among patients with a GFR of less than 80 ml/min. The ratio of 1-84 PTH/iPTH demonstrated a significant tendency to decrease in the order of patients with normal renal function (0.928 +/- 0.182), those with renal dysfunction (0.836 +/- 0.186; P < 0.05 vs patients with GFR > 80 ml/min [i.e., normal renal function]), and those with maintenance hemodialysis (0.618 +/- 0.123; P < 0.01 vs patients with GFR > 80 ml/min). The plasma levels of 1-84 PTH and conventional iPTH showed a close correlation in dialysis patients. Neither 1-84 PTH levels nor secondary parameters calculated from them showed a better correlation with bone metabolic markers than iPTH levels. CONCLUSIONS: Circulating large C-terminal PTH fragment levels are increased in uremic patients. However, this noninvasive study failed to demonstrate the superiority of the specific 1-84 assay compared with the conventional iPTH assay to evaluate bone metabolism.